Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Teladoc Health
TDOC
$1.59B
| $118M | 0.06% |
1,367,128
-405,584
| -23% | -$28.9M |
|
|
NBL
352
DELISTED
Noble Energy, Inc.
NBL
| $117M | 0.06% |
3,760,993
+456,383
| +14% | +$14.6M |
|
353
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $117M | 0.06% |
544,183
+147,914
| +37% | +$31.5M |
|
354
Travelers Companies
TRV
$81.4B
| $117M | 0.06% |
901,801
+22,644
| +3% | +$2.92M |
|
355
Aflac
AFL
$64.4B
| $117M | 0.06% |
2,483,364
+258,490
| +12% | +$11.8M |
|
356
Tapestry
TPR
$29.6B
| $117M | 0.06% |
2,322,463
+606,751
| +35% | +$29.7M |
|
357
SBA Communications
SBAC
$18.3B
| $117M | 0.06% |
725,789
-222,908
| -23% | -$35.5M |
|
|
DPLO
358
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $114M | 0.06% |
5,892,046
+506,878
| +9% | +$10.8M |
|
359
F5
FFIV
$23B
| $114M | 0.06% |
572,454
+423,915
| +285% | +$77.6M |
|
360
AutoZone
AZO
$50.2B
| $113M | 0.06% |
146,048
+19,236
| +15% | +$14.2M |
|
361
BWX Technologies
BWXT
$16.1B
| $113M | 0.06% |
1,811,010
-6,642
| -0.4% | -$421K |
|
362
Alliant Energy
LNT
$19.1B
| $113M | 0.06% |
2,659,734
-42,936
| -2% | -$1.84M |
|
363
OSI Systems
OSIS
$3.54B
| $113M | 0.06% |
1,476,691
-3,489
| -0.2% | -$271K |
|
|
COL
364
DELISTED
Rockwell Collins
COL
| $112M | 0.06% |
794,866
+62,135
| +8% | +$8.56M |
|
365
TransUnion
TRU
$14.9B
| $111M | 0.06% |
1,513,751
+195,709
| +15% | +$14.5M |
|
|
NTUS
366
DELISTED
Natus Medical Inc
NTUS
| $111M | 0.06% |
3,111,761
+396,772
| +15% | +$14M |
|
367
MakeMyTrip
MMYT
$4.96B
| $111M | 0.06% |
4,034,075
-21
| -0% | -$670 |
|
368
Cable One
CABO
$219M
| $111M | 0.06% |
125,255
+9,710
| +8% | +$7.72M |
|
369
Xcel Energy
XEL
$50.4B
| $110M | 0.06% |
2,339,114
-861,085
| -27% | -$40.7M |
|
370
W.W. Grainger
GWW
$65.8B
| $110M | 0.06% |
307,761
+102,541
| +50% | +$35.3M |
|
371
EOG Resources
EOG
$75.4B
| $110M | 0.06% |
862,163
+287,515
| +50% | +$35M |
|
372
Stryker
SYK
$129B
| $110M | 0.06% |
616,377
+25,670
| +4% | +$4.38M |
|
373
Delta Air Lines
DAL
$56.6B
| $109M | 0.06% |
1,883,703
+26,856
| +1% | +$1.48M |
|
|
EV
374
DELISTED
Eaton Vance Corp.
EV
| $109M | 0.06% |
2,065,901
-80,061
| -4% | -$4.24M |
|
375
West Pharmaceutical
WST
$23.4B
| $108M | 0.06% |
876,805
+1,082
| +0.1% | +$121K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.